Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of dextromethorphan and methylphenidate is not a standard or approved combination drug product. However, information about the potential interaction between these two medications when taken together can be provided. Dextromethorphan is commonly used as a cough suppressant that works by affecting the brain's cough center. It's found in many over-the-counter cold and cough medications, often in combination with other ingredients like guaifenesin or phenylpropanolamine. Methylphenidate is a central nervous system stimulant used primarily to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain. According to search results, there is limited evidence of direct interaction between dextromethorphan and methylphenidate. One study demonstrated that methylphenidate did not inhibit dextromethorphan metabolism in microsome preparations, suggesting there may not be a significant in vivo interaction between these two drugs. However, this doesn't rule out all potential interactions. When considering these medications together, it's important to note that methylphenidate can interact with other medications and substances. For example, methylphenidate can interact with MAOIs and certain antidepressants, potentially causing increased blood pressure and other adverse effects. If considering taking these medications together, it would be advisable to consult with a healthcare provider, as individual factors and specific formulations could affect potential interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dextromethorphan and methylphenidate combination.